Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

1.

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P.

Lancet. 1996 Apr 13;347(9007):995-9.

PMID:
8606613
[PubMed - indexed for MEDLINE]
2.

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P.

Br J Cancer. 1999 Mar;79(9-10):1522-30.

PMID:
10188901
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.

Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F; Italian Gastric Cancer Study Group.

Eur J Surg Oncol. 2004 Apr;30(3):303-8.

PMID:
15028313
[PubMed - indexed for MEDLINE]
4.

Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.

Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P.

Scand J Surg. 2007;96(1):35-40.

PMID:
17461310
[PubMed - indexed for MEDLINE]
5.

D2 or not D2? The gastrectomy question.

Lewis WG, Edwards P, Barry JD, Khan S, Dhariwal D, Hodzovic I, Allison MC, Shute K.

Gastric Cancer. 2002;5(1):29-34.

PMID:
12021857
[PubMed - indexed for MEDLINE]
6.

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K.

J Clin Oncol. 2004 Jul 15;22(14):2767-73. Epub 2004 Jun 15.

PMID:
15199090
[PubMed - indexed for MEDLINE]
Free Article
7.

Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.

Schmid A, Thybusch A, Kremer B, Henne-Bruns D.

Hepatogastroenterology. 2000 Mar-Apr;47(32):579-85.

PMID:
10791243
[PubMed - indexed for MEDLINE]
8.

The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.

Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO Jr.

J Am Coll Surg. 1995 Jul;181(1):56-64.

PMID:
7599772
[PubMed - indexed for MEDLINE]
9.

[Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].

Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A.

Suppl Tumori. 2005 May-Jun;4(3):S84-5. Italian.

PMID:
16437920
[PubMed - indexed for MEDLINE]
10.

Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M.

J Clin Oncol. 2004 Jun 1;22(11):2069-77. Epub 2004 Apr 13.

PMID:
15082726
[PubMed - indexed for MEDLINE]
Free Article
12.

Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases.

Degiuli M, Sasako M, Ponzetto A, Allone T, Soldati T, Calgaro M, Balcet F, Bussone R, Olivieri F, Scaglione D, Danese F, Morino M, Calderini P, Capussotti L, Fronda G, Garavoglia M, Locatelli L, Dellepiane M, Rossini FP, Calvo F.

Eur J Surg Oncol. 1997 Aug;23(4):310-4.

PMID:
9315058
[PubMed - indexed for MEDLINE]
13.

D2 lymphadenectomy in the management of gastric cancer.

McCullough JA, Evoy D, Sweeney KJ, Meyers C, Ravi N, Keeling N, Byrne PJ, Reynolds JV.

Ir J Med Sci. 2003 Jul-Sep;172(3):132-5.

PMID:
14700116
[PubMed - indexed for MEDLINE]
14.

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.

Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, et al.

Lancet. 1995 Mar 25;345(8952):745-8.

PMID:
7891484
[PubMed - indexed for MEDLINE]
15.

[D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].

Bittorf BR, Günther F, Merkel S, Horbach T, Hohenberger W, Günther K.

Chirurg. 2002 Apr;73(4):336-47. German.

PMID:
12063918
[PubMed - indexed for MEDLINE]
16.

Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.

Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N.

Anticancer Res. 2000 Mar-Apr;20(2B):1285-9.

PMID:
10810436
[PubMed - indexed for MEDLINE]
17.

Extended lymphadenectomy in gastric cancer: when, for whom and why.

Roukos DH.

Ann R Coll Surg Engl. 1998 Jan;80(1):16-24. Review.

PMID:
9579122
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

[Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].

Ruiz E, Sanchez J, Celis J, Payet E, Berrospi F, Chavez I, Young F.

Rev Gastroenterol Peru. 2009 Apr-Jun;29(2):124-31. Spanish.

PMID:
19609327
[PubMed - indexed for MEDLINE]
20.

[The role of superextended lymphadenectomy (D4) in gastric cancer].

Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Di Lernia S, Boniardi M, Bramerio MA.

Minerva Chir. 2004 Aug;59(4):325-35. Italian.

PMID:
15278027
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk